CRWM
PFE icon

Castle Rock Wealth Management’s Pfizer PFE Stock Holding History

Castle Rock Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$402K Buy
14,619
+26
+0.2% +$692 0.08% 186
2026
Q2 		$348K Sell
14,593
-406
-3% -$10.6K 0.07% 207
2026
Q1 		$425K Buy
14,999
+482
+3% +$12.8K 0.09% 174
2025
Q4 		$373K Sell
14,517
-1,335
-8% -$33.7K 0.08% 189
2025
Q3 		$426K Buy
15,852
+2,632
+20% +$65K 0.09% 172
2025
Q2 		$323K Buy
+13,220
New +$308K 0.08% 200
2024
Q4 		– Sell
-6,881
Closed -$203K – 256
2024
Q3 		$203K Sell
6,881
-5,517
-44% -$161K 0.05% 240
2024
Q2 		$350K Buy
12,398
+1,423
+13% +$39.2K 0.09% 180
2024
Q1 		$298K Sell
10,975
-18,528
-63% -$514K 0.08% 191
2023
Q4 		$863K Buy
29,503
+1,327
+5% +$40.1K 0.26% 108
2023
Q3 		$935K Buy
28,176
+3,406
+14% +$120K 0.31% 79
2023
Q2 		$903K Buy
24,770
+17,040
+220% +$663K 0.31% 71
2023
Q1 		$297K Buy
7,730
+1,728
+29% +$74.6K 0.11% 168
2022
Q4 		$266K Buy
+6,002
New +$288K 0.12% 182
2022
Q3 		– Sell
-4,701
Closed -$251K – 213
2022
Q2 		$251K Buy
4,701
+10
+0.2% +$510 0.13% 172
2022
Q1 		$235K Sell
4,691
-728
-13% -$37.8K 0.11% 205
2021
Q4 		$286K Buy
5,419
+9
+0.2% +$446 0.12% 202
2021
Q3 		$261K Sell
5,410
-346
-6% -$15.3K 0.09% 223
2021
Q2 		$277K Buy
5,756
+212
+4% +$8.24K 0.1% 209
2021
Q1 		$214K Buy
+5,544
New +$197K 0.09% 235
2018
Q1 		– Sell
-6,629
Closed -$228K – 112
2017
Q4 		$228K Buy
+6,629
New +$226K 0.44% 86

Other funds holding PFE

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Castle Rock Wealth Management's PFE Position: Q3 2026 in Review

Castle Rock Wealth Management increased its Pfizer (PFE) stake by 0.18% in Q3 2026, buying an estimated $692 and bringing the position to 14,619 shares worth $402K. The position accounts for 0.08% of the portfolio, ranked #186.

Castle Rock Wealth Management first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. The position peaked at $935K in Q3 2023. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Castle Rock Wealth Management held 14,619 shares of Pfizer worth $402K as of Q3 2026.
  • Castle Rock Wealth Management bought 26 Pfizer shares in Q3 2026, an estimated $692.
  • Pfizer made up 0.08% of Castle Rock Wealth Management's portfolio in Q3 2026, its #186 holding.
  • Castle Rock Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
  • Castle Rock Wealth Management's Pfizer position peaked at $935K in Q3 2023.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.